Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities

Table 2 **Multivariate logistic regression of correlates associated with dose 3 completion (N = 430*)**

	aOR	95% CI		p-value
Accelerated Treatment Group	1.92	1.34	2.58	<0.001
Age (continuous)	1.05	1.03	1.07	<0.001
Less healthy (Likert Scale 1–5)	1.26	1.05	1.5	0.01
Main source of syringes past 3 months
Direct from SEP	Reference
Direct from pharmacy	0.43	0.179	1.04	0.60
From SEP customer	0.33	0.19	0.58	<0.001
Other	0.68	0.39	1.18	0.17

*165 observations were excluded due to missing values for the outcome or explanatory variables.

ISSN: 1471-2458